Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms
- PMID: 39954136
- DOI: 10.1007/s10048-025-00810-1
Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms
Abstract
Parkinson's disease (PD) is a multifaceted neurodegenerative disorder with both non-motor and motor symptoms. Variants in the glucosylceramidase beta 1 (GBA1) gene are the strongest genetic risk factor for PD, while homozygous or compound heterozygous variants in this gene classically cause Gaucher disease (GD). This study presents an early-onset PD patient with a homozygous GBA1 deletion. Whole-exome sequencing (WES) was performed, and the identified variant was validated via Sanger sequencing. The variant was classified according to ACMG guidelines and ClinGen updates. The patient, a Brazilian female of mixed ethnicity, exhibited the full spectrum of classical motor and non-motor PD symptoms without evident hallmarks of GD. The identified homozygous GBA1 variant (NM_000157.4:c.222_224del; p.T75del; rs761621516) has a very low global allele frequency (0.00003284) and is associated with reduced enzymatic activity. This variant exhibits a founder effect among individuals of African descent. This case highlights an intricate genotype-phenotype landscape for GBA1 variants, underscoring the role of homozygous GBA1 variants in PD pathogenesis.
Keywords: GBA1; Early-onset Parkinson’s disease; Gaucher disease; Parkinson’s disease; Whole exome sequencing.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373(9680):2055-66. https://doi.org/10.1016/S0140-6736(09)60492-X . Erratum in: Lancet. 2009 Aug 29;374(9691):684
-
- Velez-Pardo C, Lorenzo-Betancor O, Jimenez-Del-Rio M, Moreno S, Lopera F, Cornejo-Olivas M et al (2019) The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism Relat Disord 63:204–208. https://doi.org/10.1016/j.parkreldis.2019.01.030 - DOI - PubMed - PMC
-
- Salles P, Tirapegui JM, Chaná-Cuevas P (2024) Genetics of Parkinson's disease: Dominant forms and GBA. Neurology Perspectives 2267–0496. https://doi.org/10.1016/j.neurop.2024.100153 .
-
- Menozzi E, Schapira AHV (2021) Exploring the Genotype-Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers. Front Neurol. https://doi.org/10.3389/fneur.2021.694764 - DOI - PubMed - PMC
-
- Vieira SRL, Mezabrovschi R, Toffoli M, Del Pozo SL, Menozzi E, Mullin S et al (2024) Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease. Mov Disord. https://doi.org/10.1002/mds.30006 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical